April 19, 2022
MIMETAS participates in €325 million Oncode-PACT initiative to accelerate and improve oncology drug development
LEIDEN, The Netherlands, April 14, 2022 - MIMETAS, a global leader in organ-on-chip-based disease models,…
April 18, 2022
Flu-COVID Combination Test the Next Target for Ellume as New BioHealth Capital Region Facility Opens
A Brisbane-based company that has targeted the premium end of the COVID home diagnosis boom…